These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20036596)

  • 1. DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients.
    Arif M; Islam MR; Waise TM; Hassan F; Mondal SI; Kabir Y
    Diabetes Metab; 2010 Feb; 36(1):51-7. PubMed ID: 20036596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetes.
    Pieme CA; Tatangmo JA; Simo G; Biapa Nya PC; Ama Moor VJ; Moukette Moukette B; Tankeu Nzufo F; Njinkio Nono BL; Sobngwi E
    BMC Res Notes; 2017 Mar; 10(1):141. PubMed ID: 28356165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes.
    Song F; Jia W; Yao Y; Hu Y; Lei L; Lin J; Sun X; Liu L
    Clin Sci (Lond); 2007 Jun; 112(12):599-606. PubMed ID: 17209802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia.
    Adeshara K; Di Marco E; Bordino M; Gordin D; Bernardi L; Cooper ME; Groop PH;
    Cardiovasc Diabetol; 2024 Sep; 23(1):350. PubMed ID: 39342285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients.
    Soliman GZ
    Singapore Med J; 2008 Feb; 49(2):129-36. PubMed ID: 18301840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients.
    Komosińska-Vassev K; Olczyk K; Olczyk P; Winsz-Szczotka K
    Diabetes Res Clin Pract; 2005 Jun; 68(3):207-16. PubMed ID: 15936462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative Stress and Asprosin Levels in Type 2 Diabetic Patients with Good and Poor Glycemic Control.
    Senyigit A; Durmus S; Gelisgen R; Uzun H
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334889
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
    Lodovici M; Giovannelli L; Pitozzi V; Bigagli E; Bardini G; Rotella CM
    Mutat Res; 2008 Feb; 638(1-2):98-102. PubMed ID: 17964614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative protein damage in early stage Type 1 diabetic patients.
    Telci A; Cakatay U; Salman S; Satman I; Sivas A
    Diabetes Res Clin Pract; 2000 Dec; 50(3):213-23. PubMed ID: 11106836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications.
    Martín-Gallán P; Carrascosa A; Gussinyé M; Domínguez C
    Free Radic Biol Med; 2003 Jun; 34(12):1563-74. PubMed ID: 12788476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malondialdehyde and Zinc May Relate to Severity of Microvascular Complications in Diabetes: A Preliminary Study on Older Adults with Type 2 Diabetes Mellitus in Northeast China.
    Sun M; Yan G; Sun S; Li X; Sun W; Wang Y
    Clin Interv Aging; 2024; 19():1141-1151. PubMed ID: 38948168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants.
    Jain N; Naseem I; Ahmad J
    Fundam Clin Pharmacol; 2009 Apr; 23(2):197-205. PubMed ID: 19645814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus.
    Aouacheri O; Saka S; Krim M; Messaadia A; Maidi I
    Can J Diabetes; 2015 Feb; 39(1):44-9. PubMed ID: 25065473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity.
    Bandeira Sde M; Guedes Gda S; da Fonseca LJ; Pires AS; Gelain DP; Moreira JC; Rabelo LA; Vasconcelos SM; Goulart MO
    Oxid Med Cell Longev; 2012; 2012():819310. PubMed ID: 23259029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.
    Alper G; Irer S; Duman E; Caglayan O; Yilmaz C
    Endocr Res; 2005; 31(3):199-212. PubMed ID: 16392622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria.
    Yadav D; Mishra M; Joseph AZ; Subramani SK; Mahajan S; Singh N; Bisen PS; Prasad GB
    Obes Res Clin Pract; 2015; 9(2):158-67. PubMed ID: 25890429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
    Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
    Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus.
    Pasaoglu H; Sancak B; Bukan N
    Tohoku J Exp Med; 2004 Jul; 203(3):211-8. PubMed ID: 15240931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.